Cargando…
Early prostate specific antigen decline and its velocity are independent predictive factors for outcomes of mCRPC patients treated with abiraterone acetate
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785553/ https://www.ncbi.nlm.nih.gov/pubmed/35074001 http://dx.doi.org/10.1186/s40779-021-00364-x |
| _version_ | 1784638986870849536 |
|---|---|
| author | Wang, Jiang-Yi Yu, Guo-Peng Li, Long Lin, Guo-Wen Ye, Ding-Wei |
| author_facet | Wang, Jiang-Yi Yu, Guo-Peng Li, Long Lin, Guo-Wen Ye, Ding-Wei |
| author_sort | Wang, Jiang-Yi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8785553 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87855532022-01-24 Early prostate specific antigen decline and its velocity are independent predictive factors for outcomes of mCRPC patients treated with abiraterone acetate Wang, Jiang-Yi Yu, Guo-Peng Li, Long Lin, Guo-Wen Ye, Ding-Wei Mil Med Res Letter to the Editor BioMed Central 2022-01-24 /pmc/articles/PMC8785553/ /pubmed/35074001 http://dx.doi.org/10.1186/s40779-021-00364-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Letter to the Editor Wang, Jiang-Yi Yu, Guo-Peng Li, Long Lin, Guo-Wen Ye, Ding-Wei Early prostate specific antigen decline and its velocity are independent predictive factors for outcomes of mCRPC patients treated with abiraterone acetate |
| title | Early prostate specific antigen decline and its velocity are independent predictive factors for outcomes of mCRPC patients treated with abiraterone acetate |
| title_full | Early prostate specific antigen decline and its velocity are independent predictive factors for outcomes of mCRPC patients treated with abiraterone acetate |
| title_fullStr | Early prostate specific antigen decline and its velocity are independent predictive factors for outcomes of mCRPC patients treated with abiraterone acetate |
| title_full_unstemmed | Early prostate specific antigen decline and its velocity are independent predictive factors for outcomes of mCRPC patients treated with abiraterone acetate |
| title_short | Early prostate specific antigen decline and its velocity are independent predictive factors for outcomes of mCRPC patients treated with abiraterone acetate |
| title_sort | early prostate specific antigen decline and its velocity are independent predictive factors for outcomes of mcrpc patients treated with abiraterone acetate |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785553/ https://www.ncbi.nlm.nih.gov/pubmed/35074001 http://dx.doi.org/10.1186/s40779-021-00364-x |
| work_keys_str_mv | AT wangjiangyi earlyprostatespecificantigendeclineanditsvelocityareindependentpredictivefactorsforoutcomesofmcrpcpatientstreatedwithabirateroneacetate AT yuguopeng earlyprostatespecificantigendeclineanditsvelocityareindependentpredictivefactorsforoutcomesofmcrpcpatientstreatedwithabirateroneacetate AT lilong earlyprostatespecificantigendeclineanditsvelocityareindependentpredictivefactorsforoutcomesofmcrpcpatientstreatedwithabirateroneacetate AT linguowen earlyprostatespecificantigendeclineanditsvelocityareindependentpredictivefactorsforoutcomesofmcrpcpatientstreatedwithabirateroneacetate AT yedingwei earlyprostatespecificantigendeclineanditsvelocityareindependentpredictivefactorsforoutcomesofmcrpcpatientstreatedwithabirateroneacetate |